BridgeMD
Pulmonary Embolism & Anticoagulation Evaluation in Cancer Patient - PEACE
EU CTIS ID: 2025-524110-28-00
What this study is testing
To compare withholding anticoagulant treatment versus initiating anticoagulant treatment in cancer patients with incidental subsegmental pulmonary embolism, measuring mortality, bleeding, re-thrombosis, cancer treatment continuation, and quality of life.
- Therapeutic use (Phase IV)
A plain-language read of the study's public EU CTIS listing. The study team confirms the details.
Who can take part
You may be able to join if
- 1 Active cancer
- 2 Age more than or equal to 18
- 3 Less than or equal to three incidental SSPEs detected on routine imaging
- 4 Planned routine follow-up CT scan within 3-4 months
- 5 Able to provide informed consent
- 6 Access to smartphone (participant or family member)
You likely can't join if
- 1 Other indications for anticoagulation treatment
- 2 Currently receiving anticoagulation treatment
- 3 Clinical signs of deep venous thrombosis
- 4 Previous venous thromboembolism (within 10 years)
- 5 Immobilisation > 5 consecutive days
- 6 Cancer surgery within the past 1 month
See the full eligibility criteria
- 1 Active cancer
- 2 Age more than or equal to 18
- 3 Less than or equal to three incidental SSPEs detected on routine imaging
- 4 Planned routine follow-up CT scan within 3-4 months
- 5 Able to provide informed consent
- 6 Access to smartphone (participant or family member)
- 1 Other indications for anticoagulation treatment
- 2 Currently receiving anticoagulation treatment
- 3 Clinical signs of deep venous thrombosis
- 4 Previous venous thromboembolism (within 10 years)
- 5 Immobilisation > 5 consecutive days
- 6 Cancer surgery within the past 1 month
- 7 Inability to read and speak Danish sufficiently for informed consent and study participation
- 8 Pregnancy
The study team makes the final eligibility decision.
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 65+ years, 18-64 years. The study team makes the final eligibility decision.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from EU CTIS; the study team decides eligibility.